Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 known ✓ | P27487 | 2/20 | 0.46 |
| ▸ | MAOB known ✓ | P27338 | 1/20 | 0.45 |
| ▸ | GAA known ✓ | P10253 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.64 |
| ▸ | MMP2 | P08253 | 2/20 | 0.49 |
| ▸ | IDO1 | P14902 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.46 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.46 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.45 |
| ▸ | MC4R | P32245 | 1/20 | 0.45 |
| ▸ | FAP | Q12884 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1230535 | 1.00 | ALDH1A1 (0.64) | ALDH1A1MMP2IDO1MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL4371678 | 1.00 | ALDH1A1 (0.64) | ALDH1A1MMP2IDO1MEN1KMT2A | |
| SCHEMBL4367409 | 0.98 | ALDH1A1 (0.62) | ALDH1A1MMP2IDO1MEN1KMT2A | |
| SCHEMBL3317059 | 0.98 | ALDH1A1 (0.62) | ALDH1A1MMP2IDO1MEN1KMT2A | |
| SCHEMBL240405 | 0.98 | ALDH1A1 (0.62) | ALDH1A1MMP2IDO1MEN1KMT2A | |
| SCHEMBL27546222 | 0.97 | ALDH1A1 (0.61) | ALDH1A1MMP2IDO1MEN1KMT2A | |
| SCHEMBL4097192 | 0.92 | ALDH1A1 (0.56) | ALDH1A1MMP2MEN1KMT2ADPP4 | |
| SCHEMBL8211198 | 0.92 | ALDH1A1 (0.56) | ALDH1A1MMP2MEN1KMT2ADPP4 | |
| Hydrochloric Acid SCHEMBL1859934 | 0.87 | ALDH1A1 (0.50) | ALDH1A1MMP2IDO1LMNADPP4 | |
| Hydrochloric Acid SCHEMBL17707255 | 0.87 | ALDH1A1 (0.50) | ALDH1A1MMP2IDO1LMNADPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 308 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119193761-A | Test paper and method for semi-quantitatively detecting leucine aminopeptidase | 广州达安基因股份有限公司 | 2024-12-27 | — | — | CN | claimed |
| CN-113527399-B | Ginsenoside CK derivative and application thereof in preparation of antitumor drugs | 陕西巨子生物技术有限公司 | 2023-01-31 | — | — | CN | claimed |
| CN-113527399-A | Ginsenoside CK derivative and application thereof in preparation of antitumor drugs | 陕西巨子生物技术有限公司 | 2021-10-22 | — | — | CN | claimed |
| WO-2004063175-A1 | A NOVEL AND AN IMPROVED PROCESS FOR THE PREPARATION OF (S)-4-(4-AMINOBENZYL)-2- OXAZOLIDINONE | NATCO PHARMA LIMITED (IN) | 2004-07-29 | — | — | WO | claimed |
| EP-0843672-B1 | ONE POT SYNTHESIS OF 2-OXAZOLIDINONE DERIVATIVES | ASTRAZENECA AB (SE) | 2002-11-13 | — | — | EP | claimed |
| EP-0843673-B1 | ONE POT SYNTHESIS OF 2-OXAZOLIDINONE DERIVATIVES | ASTRAZENECA AB (SE) | 2001-11-07 | — | — | EP | claimed |
| US-6303791-B1 | REACTING METHYL 4-NITRO-(L)-PHENYLALANINATE HYDROCHLORIDE WITH N-BUTYL CHLOROFORMATE TO FORM CARBAMATE, REDUCING NITRO GROUP TO AMINE AND ESTER GROUP TO ALCOHOL, CYCLIZING, FORMING DIAZONIUM SALT, REDUCING, PERFORMING FISCHER REACTION | ZENECA LIMITED (GB) | 2001-10-16 | — | — | US | claimed |
| US-6084103-A | FORMING A CARBAMATE FROM METHYL 4-NITRO-(L)-PHENYLALANINATE HYDROCHLORIDE; REDUCING THE NITRO AND ESTER GROUPS; RING CLOSURE FREE OF PHOSGENE; FORMING A DIAZONIUM SALT WITHOUT USING TIN CHLORIDE; FISCHER REACTION; MIGRAINES; 5HT1-AGONIST | ZENECA LIMITED (GB) | 2000-07-04 | — | — | US | claimed |
| EP-0843673-A1 | ONE POT SYNTHESIS OF 2-OXAZOLIDINONE DERIVATIVES | ZENECA LIMITED (GB) | 1998-05-27 | — | — | EP | claimed |
| EP-0843672-A1 | ONE POT SYNTHESIS OF 2-OXAZOLIDINONE DERIVATIVES | ZENECA LIMITED (GB) | 1998-05-27 | — | — | EP | claimed |
| WO-1997006163-A1 | ONE POT SYNTHESIS OF 2-OXAZOLIDINONE DERIVATIVES | ZENECA LIMITED (GB) | 1997-02-20 | — | — | WO | claimed |
| WO-1997006162-A1 | ONE POT SYNTHESIS OF 2-OXAZOLIDINONE DERIVATIVES | ZENECA LIMITED (GB) | 1997-02-20 | — | — | WO | claimed |
| CN-119193761-A | Test paper and method for semi-quantitatively detecting leucine aminopeptidase | 广州达安基因股份有限公司 | 2024-12-27 | — | — | CN | disclosed |
| CN-119193761-A | Test paper and method for semi-quantitatively detecting leucine aminopeptidase | 广州达安基因股份有限公司 | 2024-12-27 | — | — | CN | disclosed |
| EP-4425181-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | Bertis Inc (KR) | 2024-09-04 | — | — | EP | disclosed |
| CN-118344557-A | Diketopiperazine-based polyurethane elastomer and preparation method and application thereof | 天津科技大学 | 2024-07-16 | — | — | CN | disclosed |
| WO-1986006384-A1 | METHOD OF FORMING A METAL CHELATE PROTEIN CONJUGATE | GANSOW OTTO A (US) | 1986-11-06 | — | — | WO | disclosed |
| US-4587046-A | Drug-carrier conjugates | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1986-05-06 | — | — | US | disclosed |
| EP-0117089-A1 | Beta-adrenergic antagonist compounds and derivatives of beta-adrenergic antagonists | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1984-08-29 | — | — | EP | disclosed |
| EP-0094844-A2 | Drug-carrier conjugates | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1983-11-23 | — | — | EP | disclosed |